அணி மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from அணி மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In அணி மருந்துகள் Today - Breaking & Trending Today
ANI Pharmaceuticals, inc (ANIP) Q2 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Bolton-St. Johns comes to D.C. politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.
Copy shortlink: ANI Pharmaceuticals, the Baudette-based maker of generic and specialty drugs, announced plans to acquire Novitium Pharma in a $163.5 million deal that should increase its drug-commercialization capabilities. Strengthening our well-established generics business with enhanced development capabilities and increased focus on niche opportunities is a key pillar of ANI s growth strategy, Nikhil Lalwani, ANI s chief executive, said in a statement. Novitium, based in East Windsor, N.J., makes niche generic products in liquid, capsule, tablet and powder forms. It has a 50,000-square-foot facility for manufacturing and research and is adding 20,000 square feet to it. Lalwani said the state-of-the-art manufacturing facility is a key attraction in the deal. He also said ANI would be able to add more size to its contract development and manufacturing business. ....
ANI: Q4 Earnings Snapshot FacebookTwitterEmail BAUDETTE, Minn. (AP) ANI Pharmaceuticals Inc. (ANIP) on Tuesday reported a loss of $3.6 million in its fourth quarter. On a per-share basis, the Baudette, Minnesota-based company said it had a loss of 30 cents. Earnings, adjusted for one-time gains and costs, were 80 cents per share. The drugmaker posted revenue of $57.3 million in the period. For the year, the company reported a loss of $22.5 million, or $1.88 per share, swinging to a loss in the period. Revenue was reported as $208.5 million. ANI shares have climbed 4.5% since the beginning of the year. The stock has fallen 29% in the last 12 months. ....
ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.